| P50 | author | Eleonora Turrini | Q43245394 |
| | Carmela Fimognari | Q43245399 |
| | Anna Minarini | Q57078501 |
| P2093 | author name string | Vincenzo Tumiatti | |
| | Elena Simoni | |
| | Andrea Milelli | |
| P2860 | cites work | Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells | Q21195157 |
| | High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate | Q24534121 |
| | Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis | Q24641921 |
| | Epigenetic diet: impact on the epigenome and cancer | Q27022002 |
| | Mechanisms of action of isothiocyanates in cancer chemoprevention: an update | Q28248643 |
| | Microtubules as a target for anticancer drugs | Q28253993 |
| | Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research | Q28269727 |
| | Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate | Q28383320 |
| | Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells | Q28397373 |
| | Sulforaphane potentiates RNA damage induced by different xenobiotics | Q28482480 |
| | Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China | Q28732170 |
| | Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes | Q29398493 |
| | Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis | Q29614537 |
| | Cisplatin: mode of cytotoxic action and molecular basis of resistance | Q29615385 |
| | Reversibility of apoptosis in cancer cells | Q30485754 |
| | Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates | Q32128748 |
| | In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma | Q33286433 |
| | A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin | Q33540751 |
| | Allyl isothiocyanate as a cancer chemopreventive phytochemical. | Q33622654 |
| | Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo | Q33724512 |
| | Chemoprevention of cancer | Q33846248 |
| | The chemical diversity and distribution of glucosinolates and isothiocyanates among plants | Q33934528 |
| | High levels of Nrf2 determine chemoresistance in type II endometrial cancer | Q33959077 |
| | Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells | Q34074470 |
| | Sensitization of non-small cell lung cancer cells to cisplatin by naturally occurring isothiocyanates | Q34076604 |
| | Inhibition of carcinogenesis by isothiocyanates | Q34119188 |
| | Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships | Q34159403 |
| | Cancer epidemiology in the last century and the next decade | Q34253597 |
| | Glucosinolates and isothiocyanates in health and disease. | Q34274313 |
| | Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate | Q34473316 |
| | Signal transduction pathways of taxanes-induced apoptosis | Q34534026 |
| | Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans | Q34706257 |
| | Multi-targeted prevention of cancer by sulforaphane | Q34781826 |
| | Are isothiocyanates potential anti-cancer drugs? | Q34979394 |
| | Doxorubicin pathways: pharmacodynamics and adverse effects | Q35048393 |
| | Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma | Q35143496 |
| | Gemcitabine in cervical cancer | Q35202990 |
| | Proteins as binding targets of isothiocyanates in cancer prevention | Q35230296 |
| | Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway. | Q35283173 |
| | The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates. | Q35747310 |
| | Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora | Q36201654 |
| | Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures | Q36226632 |
| | Etoposide, topoisomerase II and cancer | Q36230274 |
| | Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis | Q36418052 |
| | Telomerase therapeutics for cancer: challenges and new directions | Q36506309 |
| | Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin | Q36580055 |
| | hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells | Q36614496 |
| | Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase | Q36618045 |
| | Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism | Q36843744 |
| | Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy | Q36920745 |
| | Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner | Q37293802 |
| | Aldehyde dehydrogenase as a marker for stem cells | Q37347494 |
| | NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer | Q37423465 |
| | Biosynthesis of glucosinolates--gene discovery and beyond | Q37715312 |
| | Anti-angiogenic effects of dietary isothiocyanates: Mechanisms of action and implications for human health | Q37801027 |
| | Nrf2: control of sensitivity to carcinogens | Q37849195 |
| | Pharmacokinetics and pharmacodynamics of isothiocyanates. | Q37873490 |
| | Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells | Q39581417 |
| | Effects of phenylethyl isothiocyanate and its metabolite on cell-cycle arrest and apoptosis in LNCaP human prostate cancer cells | Q39713370 |
| | Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis | Q39747791 |
| | Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells | Q39861400 |
| | Synergistic inhibitory effect of sulforaphane and 5-fluorouracil in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma | Q39930973 |
| | The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells | Q40110170 |
| | Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line | Q40130426 |
| | Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation | Q40150731 |
| | Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations | Q40255489 |
| | p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. | Q40371664 |
| | Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo | Q40426261 |
| | Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. | Q40447260 |
| | Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage | Q40529202 |
| | Role of MRP2 and GSH in intrahepatic cycling of toxins | Q40780576 |
| | Cellular pharmacology of quinone bioreductive alkylating agents | Q40848126 |
| | Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics | Q43041593 |
| | Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane | Q43550903 |
| | High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate | Q43636434 |
| | Protein kinase C modulates telomerase activity in human cervical cancer cells | Q43772323 |
| | Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis | Q43965273 |
| | Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine | Q44211838 |
| | Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography–tandem mass spectrometry | Q44658811 |
| | A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. | Q45020400 |
| | Effect of organic isothiocyanates on breast cancer resistance protein (ABCG2)-mediated transport | Q45222334 |
| | Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling | Q46336155 |
| | ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. | Q46792290 |
| | Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. | Q46813473 |
| | Design, synthesis and biological evaluation of new naphtalene diimides bearing isothiocyanate functionality. | Q50791285 |
| | Studies on the mechanism of the inhibition of human leukaemia cell growth by dietary isothiocyanates and their cysteine adducts in vitro. | Q51080568 |
| | Enhancement of cisplatin cytotoxicity by benzyl isothiocyanate in HL-60 cells. | Q54313490 |
| | ABC Transporters and Isothiocyanates | Q58005850 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 25-38 | |
| P577 | publication date | 2013-10-03 | |
| P1433 | published in | Expert Opinion on Drug Metabolism & Toxicology | Q5421205 |
| P1476 | title | Exploring the effects of isothiocyanates on chemotherapeutic drugs | |
| P478 | volume | 10 | |